The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase ib trial of dose-escalating AZD1775 in combination with concurrent radiation and cisplatin for intermediate and high risk head and neck squamous cell carcinoma.
 
Bhishamjit S. Chera
Employment - Tomotherapy
 
Gaorav P. Gupta
No Relationships to Disclose
 
Jared Weiss
Stock and Other Ownership Interests - Pharmacyclics
Consulting or Advisory Role - AstraZeneca; Biodesix; Clovis Oncology; EMD Serono; Lilly; OncoPlex Diagnostics
Research Funding - Acceleron Pharma; Astellas Pharma; Celgene; GlaxoSmithKline; MedImmune; Pfizer
 
Juneko E. Grilley-Olson
Consulting or Advisory Role - Sanofi
Research Funding - Bayer; GlaxoSmithKline; Kyowa Hakko Kirin; Morphotek; NanoCarrier; Novartis; Peregrine Pharmaceuticals; ZIOPHARM Oncology
 
Dominic T. Moore
No Relationships to Disclose
 
Jose Zevallos
No Relationships to Disclose
 
Trevor Hackman
No Relationships to Disclose
 
Samip Patel
No Relationships to Disclose
 
Adam M Zanation
No Relationships to Disclose
 
Mark Christian Weissler
Stock and Other Ownership Interests - Allergan; Baxter; cardinal health; carefusion; Express Scripts; Johnson & Johnson; Medtronic; Merck; Novartis; Pfizer; Stryker; Zimmer
 
David N. Hayes
Leadership - GeneCentric
Stock and Other Ownership Interests - GeneCentric
Consulting or Advisory Role - GeneCentric
Patents, Royalties, Other Intellectual Property - I hold several diagnostic patents or pending patents in the area of solid tumor diagnostics